A new fixed-dose combination (FDC) of omega-3 and atorvastatin â a medication to treat high blood cholesterol â could improve compliance and convenience among dyslipidaemia patients, according to researchers in South Korea…
阅读更多（Read More）
Novel omega-3 therapy for dyslipidaemia may improve patient compliance, convenience: South Korean study
作者@inv691 - telegram BAM 504790 RUB bqj
4 月 3, 2024